1.Date of occurrence of the event:2022/03/07
2.Company name:Maxigen Biotech Inc
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:N/A
6.Countermeasures:N/A
7.Any other matters that need to be specified:
Maxigen Biotech Inc. (TWSE: 1783) today announced its net revenues
for February 2022.
On a consolidated basis, revenues for February 2022 were
approximately NT$40,754 Thousand, an increase of 7.40 percent
over the same period in 2021.
Revenues for January through February 2022 totaled
NT$76.891 million, an increase of 23.29 percent compared to
the NT$62.368 million for the same period in 2021.
